Plain-English translation of NCT03340506 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Melanoma research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This is a long-term safety study for patients with melanoma, lung cancer, or other solid tumors who have already been taking and/or in a previous research study and want to keep going. The goal is to watch how safe and well-tolerated this medication remains when patients continue using it after their original trial ends. You'll keep taking the same treatment plan you were on — either one medication alone or both together — depending on what was working best for you.
Sometimes patients benefit so much from a medication during a research trial that stopping it wouldn't be in their best interest. This study exists to let those patients safely continue their treatment while doctors monitor for any long-term side effects.
You likely qualify if…
You likely don't qualify if…
You will continue taking the medication you've been on — either one drug alone or both medications together — exactly as your doctor prescribed in your previous study. You'll have regular visits with the study team to check how you're doing, monitor for any side effects, and make sure the treatment is still working well for you. The study will continue as long as you and your doctor agree the medication is helping and you're tolerating it safely.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
United States
Argentina